0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Eileen M. Bulger, MD; Ronald V. Maier, MD; Jason Sperry, MD; et al.
JAMA Surg. 2014;149(6):528-536. doi:10.1001/jamasurg.2013.4841.
Includes: CME, Supplemental Content

Original Article |  FREE
Amy L. Friedman, MD; Sarah R. Geoghegan, BSN; Noelle M. Sowers, RN; et al.
Arch Surg. 2007;142(3):278-283. doi:10.1001/archsurg.142.3.278.
Includes: CME

Invited Critique | 
Martin A. Makary, MD, MPH
Arch Surg. 2007;142(3):284. doi:10.1001/archsurg.142.3.284.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Research Letter  | 
Trends in Boxed Warnings and Withdrawals for Novel Therapeutic Drugs, 1996 Through 2012
Christine M. Cheng, PharmD; Jaekyu Shin, PharmD, MS; B. Joseph Guglielmo, PharmD
JAMA
Review  | 
Treatment of Hepatitis C:  A Systematic Review
Anita Kohli, MD, MS; Ashton Shaffer, BA; Amy Sherman, MD; et al.
JAMA
Original Investigation  | 
Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions
Wen-Hung Chung, MD, PhD; Wan-Chun Chang, MS; Yun-Shien Lee, PhD; et al.
JAMA Dermatology
Research Letter  | 
Risk for Nevus Transformation and Melanoma Proliferation and Invasion During Natalizumab Treatment:  Four Years of Dermoscopic Follow-up With Immunohistological Studies and Proliferation and Invasion Assays
Momen Pharaon, MD; Mélanie Tichet, MSc; Christine Lebrun-Frénay, MD, PhD; et al.